March 2007
New Mexico Medical Review Association
This report conveys the findings of the Independent Assessment of the access, quality, and cost-effectiveness of health care services delivered under New Mexico’s Behavioral Health Collaborative. This report fulfills the requirement of the Centers for Medicare and Medicaid Services (CMS) that state Medicaid authorities arrange for an independent assessment of a state’s 1915(b) waiver programs. The Lewin Group has reviewed the access- and quality-related state contractual requirements, ValueOptions’ proposal to the State of New Mexico, Managed Care Audit, ValueOptions’ provider network, selected reports, provider satisfaction survey, national performance standards and MHSIP performance, ValueOptions’ Quality Management Program, and various financial reports. Based on the comprehensive review of submitted reports and data related to consumer and provider satisfaction, the program is off to a strong start in some respects and a challenging start in others. ValueOptions and the Interagency Behavioral Health Purchasing Collaborative have implemented a behavioral health system that is designed to not only provide access to quality health services, but also integrate other non-medical health member needs. The State of New Mexico has set extensive and specific requirements for performance, which ValueOptions has already met or appears to be making significant progress towards. New Mexico’s behavioral health system meets CMS guidelines and requirements in terms of access, quality, and cost-effectiveness.
Client Area: State and Local Governments
Expertise Area: Medicaid and CHIP, Mental Health and Substance Abuse
October 2002
DHHS, Center for Substance Abuse Treatment
This analysis aims to compare the performance of the treatment systems located within cities in different geographic regions, an approach to performance measurement and outcomes monitoring that has not previously been done. Using the CSAT Target Cities multi-site data set, the goals of this analysis were to (1) identify and operationalize standardized performance measures that are applicable across treatment systems within cities; (2) illlustrate a type of performance measurement analysis that can be conducted at the treatment system level; (3) assess the relative performance of the treatment systems/cities using the identified performance measures; and (4) highlight the uses, benefits, constraints and data requirements for system-level performance measurement monitoring and comparisons.
Client Area: Federal Government
Expertise Area: Mental Health and Substance Abuse
June 2002
DHHS, Center for Substance Abuse Treatment
This bibliography lists books, published articles and research/evaluation studies, and government documents (including "Web" publications) published since 1980 that focus on the costs of substance abuse treatment, methods for estimating the costs of treatment, and studies of the cost effectiveness and cost benefits of substance abuse treatment. This document also identifies trends and areas where there are gaps in the literature. A companion document, Cost Effectiveness and Cost Benefit Analysis of Substance Abuse Treatment: A Literature Review, synthesizes the major findings from the reports and studies focusing on the cost effectiveness and cost benefits of substance abuse treatment identified in this bibliography.
Client Area: Federal Government
Expertise Area: Chronic Disease / Cost of Illness, Mental Health and Substance Abuse
June 2002
DHHS, Center for Substance Abuse Treatment
This literature review summarizes the major findings from books, published articles, research and evaluation studies, and government documents (including "Web" publications) published since 1980, which focus on the cost effectiveness and cost benefits of substance abuse treatment. Cost effectiveness and cost benefit studies play an important role in evaluating existing and alternative substance abuse approaches and in assessing new treatment methods. Evaluating the outcomes and costs of treatment is necessary in order to determine how to more efficiently allocate scarce resources. This document is intended to assist policymakers, researchers/evaluators, and treatment providers interested in this field to identify and acquire evidence-based information specific to their interests. This review also explores trends and areas where there are gaps in the literature.
Client Area: Federal Government
Expertise Area: Chronic Disease / Cost of Illness, Mental Health and Substance Abuse
September 2001
Office of National Drug Control Policy (ONDCP)
This report, developed for The Office of National Drug Control Policy, presents new estimates of the societal cost of drug abuse. The most recent previous estimates of drug abuse related costs are for 1995. In addition, the report provides annual estimates for 1992 through 1998 and projections for 1999 and 2000 that are consistently developed, so that trends in the overall societal cost and in component costs of drug abuse can be evaluated. In developing the report, p articular emphasis was placed on estimating the health-related consequences and costs of illicit drug abuse, including the costs of substance abuse treatment for comorbid health problems. Other major economic costs of drug abuse estimated include: premature mortality, victim loss from drug-related property and violent crime (and child abuse), social welfare services, criminal justice expenditures, workplace and household productivity impacts, and "crime career" costs.
Client Area: Federal Government
Expertise Area: Mental Health and Substance Abuse
July 2001
DHHS, Center for Substance Abuse Treatment
This document introduces a new tool available to study the costs of substance abuse treatment: the Center for Substance Abuse Treatment (CSAT) Substance Abuse Treatment Cost Allocation and Analysis Template (SATCAAT). The particular purpose and strength of the SATCAAT is the development of cost estimates for defined components and units of service that combine (often in different proportions by different providers) to constitute substance abuse treatment. The SATCAAT should be considered an example of an important approach to studying the costs of substance abuse treatment. The method is described and actual data are presented from a sample of providers in order to demonstrate the output and potential use.
Client Area: Federal Government
Expertise Area: Mental Health and Substance Abuse
July 2001
DHHS, Center for Substance Abuse Treatment
This analytic report presents the results of an analysis of the relationship between the size of providers and the cost of delivering treatment services. It was found that large providers tend to have lower costs per unit of service than small providers, although it appears that this may be partially due to delivery of lower intensity services, with uncertain implications for the outcomes of care.
Client Area: Federal Government
Expertise Area: Mental Health and Substance Abuse
July 2001
DHHS, Substance Abuse and Mental Health Services Administration (SAMHSA)
Medicaid law and regulations require States to have a Preadmission Screening and Resident Review (PASRR) program to determine whether nursing facility applicants and residents require nursing facility services and specialized mental health care. This paper reviews the literature concerning PASRR and mental health services for persons in nursing facilities. It details the Federal laws and regulations concerning PASRR, reviews key policy issues from the literature, clarifies frequently asked questions regarding the process, and identifies additional policy questions to be studied.
Client Area: Federal Government
Expertise Area: Mental Health and Substance Abuse
January 2001
DHHS, Center for Mental Health Services
This report synthesizes the experiences of seven large employers that offer generous mental health benefits to their employees. Representatives of these employers shared their views and experiences in a one-day focus group.
Client Area: Federal Government
Expertise Area: Mental Health and Substance Abuse
December 2000
National Institute on Alcohol Abuse and Alcoholism
The economic costs of alcohol abuse are estimated to have been $184.6 billion in 1998. This estimate has been developed by making a series of adjustments to the most recent comprehensive estimates that attempt to account for changes expected to affect the estimates. This new estimate represents a 25 percent increase (3.8 percent per year on average) from the $148 billion comprehensive estimate developed previously for 1992. The current update has developed new estimates for 20 major cost components and has applied various combinations of 18 different specific adjustment factors to account for 1992 to 1998 changes in, e.g.: incidence/prevalence of selected alcohol-specific consequences; population; general prices; and worker compensation (wage rates).
Client Area: Federal Government
Expertise Area: Mental Health and Substance Abuse
Showing 1 to 10 of 18 item(s)